NUES Inc. (SBA 8a Certified Firm and WOSB)

NUES Inc.,is a niche contract research organization (CRO) that brings expert talent and unique resources needed for drug development and clinical trials. NUES Inc’s distinct value proposition is our expertise in the Global South, where our clients and partners can accelerate drug discoveries. NUES Inc R&D efforts is focused on the development of new products and improvement of existing products. Its pipeline includes drugs that demonstrate both strong clinical performance and economic value. The company is developing products for rare diseases and a few other conditions. It is also focusing on reviewing known compounds, existing medicines, and abandoned pipeline assets to evaluate their efficacy as potential treatments for other indications (drug repurposing). Our pipeline spans antiviral and hematology compounds under development for arenavirus, filovirus, and sickle cell disease. Among these pipeline programs, two are in early-stage development phases. NUES Inc works in collaboration with other pharmaceutical and biotechnology companies and academic institutions to identify and prioritize promising novel treatments that complement and enhance its existing portfolio. 8(a) Certified (expires Oct 2031) WOSB